NeuroSense reports 65% death risk reduction in ALS trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. META
4. ABBV
5. SPY
6. ACN
7. BLZE
8. IBM
9. NKE
10. MU

Go back to NeuroSense reports 65% death risk reduction in ALS trial
(NASDAQ: NRSN) Delayed: 0.77 -0.02 (2.53%)
Previous Close $0.79    52 Week High $ 
Open $0.77    52 Week Low $ 
Day High $0.80    P/E N/A 
Day Low $0.75    EPS $ 
Volume 127,270       

(NASDAQ: NRSNW) Delayed: 0.09 --0 (-0%)
Previous Close $0.09    52 Week High $ 
Open $0.09    52 Week Low $ 
Day High $0.09    P/E N/A 
Day Low $0.09    EPS $ 
Volume 26,181,029